Every Form 4 that Quantum Cyber N.V. (QUCY) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow QUCY and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full QUCY filings page.
Quantum Cyber N.V. reported that Chief Financial Officer William J. Caragol received a grant of stock options on August 11, 2026. The award covers 212,500 Stock Options, each exercisable for one Ordinary Share at a conversion or exercise price of $1.37 per share and expiring on August 11, 2036. According to the grant terms, these options will vest in eighteen substantially equal monthly installments beginning on the grant date, subject to Mr. Caragol continuing to provide services through each applicable vesting date.
Quantum Cyber N.V. discloses that Chief Executive Officer and ten percent owner David E. Lazar converted several classes of Preferred Shares into Ordinary Shares after stockholder approval on April 22, 2026, permitting conversion for no additional consideration at his option.
On August 5, 2026, he converted 1,000,000 Series A, 1,000,000 Series B, 1,000,000 Series C, and 124,700 Series D Preferred Shares into Ordinary Shares, leaving 875,300 Series D Preferred Shares in his direct holdings.
O'Rourke Peter reported acquisition or exercise transactions in this Form 4 filing.
Quantum Cyber N.V. director Peter O'Rourke received a grant of 191,860 stock options on July 22, 2026, each exercisable at 1.1400 per share for Ordinary Shares and expiring August 3, 2036. The amended report corrects the transaction date, option and underlying share quantities, and post-transaction beneficial ownership, and now shows 191,860 derivative securities held directly. The options vest in eighteen substantially equal installments on each monthly anniversary of the grant date, contingent on O'Rourke continuing to provide services.
Quantum Cyber N.V. director Natan David received a grant of Stock Options (Right to Buy) covering 191,860 Ordinary Shares at an exercise price of 1.1400 per share, expiring 2036-08-03. The options vest in eighteen substantially equal monthly installments, contingent on continued service, and the corrected report shows 191,860 options beneficially owned after the transaction.
Quantum Cyber N.V. filed an amended Form 4 reporting that Chief Financial Officer William J. Caragol received a grant of 212,500 stock options to purchase Ordinary Shares at an exercise price of $1.14 per share. The options expire on 2036-08-03 and vest in eighteen substantially equal monthly installments from the grant date, contingent on continued service; the amendment corrects the previously reported transaction date.
Quantum Cyber N.V. director Louis R. Buffalino received a grant of 425,000 Stock Options (Right to Buy) on July 22, 2026. Each option is exercisable for one Ordinary Share at an exercise price of $1.14 per share and expires on August 3, 2036. The amended report corrects the date of the reported transaction. The Stock Options vest in eighteen substantially equal monthly installments from the grant date, subject to his continued service, leaving 425,000 options reported as held directly after the grant.
Quantum Cyber N.V. director Ben-Tzvi Avraham received a grant of 112,859 Ordinary Shares on July 22, 2026 at $0.00 per share, increasing his direct holdings to 252,000 shares. This amended Form 4 corrects the originally reported transaction date, shares acquired, and post-transaction beneficial ownership.
Quantum Cyber N.V. director Ben-Tzvi Avraham reported receiving a grant of 112,259 Ordinary Shares on July 31, 2026, at $0.0000 per share. After this grant, he directly owns 251,400 Ordinary Shares. The transaction is classified as a grant, award, or other acquisition and was not made under a Rule 10b5-1 trading plan.
O'Rourke Peter reported acquisition or exercise transactions in this Form 4 filing.
Quantum Cyber N.V. director O'Rourke Peter received a grant of 190,840 stock options on 2026-07-31, each exercisable at 1.1400 per share into Ordinary Shares and expiring on 2036-08-03. The options vest in eighteen substantially equal monthly installments while he continues providing services, and this grant brings his reported derivative holdings to 190,840 options.
Quantum Cyber N.V. granted director Natan David stock options on July 31, 2026 to acquire 190,840 ordinary shares at an exercise price of $1.1400 per share. The options expire on August 3, 2036 and vest in eighteen substantially equal monthly installments, conditioned on his continued service. Following this grant, he holds 190,840 stock options directly.
Quantum Cyber N.V. reported that Chief Financial Officer William J. Caragol received a grant of stock options covering 212,500 Ordinary Shares at an exercise price of $1.1400 per share, expiring on 2036-08-03. The options vest in eighteen substantially equal monthly installments, conditioned on his continued service.
Quantum Cyber N.V. reported that director Louis R. Buffalino received a grant of 425,000 stock options on 2026-07-31. These options allow him to acquire Ordinary Shares at an exercise price of $1.1400 per share and expire on 2036-08-03. Following the grant, he held all 425,000 options directly. According to the terms, the options vest in eighteen substantially equal monthly installments, provided he continues to provide services through each vesting date.
Quantum Cyber N.V. director Peter O'Rourke received a grant of stock options described as a "Stock Option (Right to Buy)." The award covers 112,859 options, each exercisable for one ordinary share at an exercise price of $1.45 per share.
The options were granted on July 6, 2026 and are scheduled to expire on July 6, 2036. The filing shows O'Rourke holding a total of 112,859 derivative securities of this type directly following the grant, indicating a compensation-related award rather than an open-market purchase or sale.
Ben-Tzvi Avraham reported acquisition or exercise transactions in this Form 4 filing.
Quantum Cyber N.V. director Ben-Tzvi Avraham reported receiving a grant of 137,141 Ordinary Shares on May 8, 2026. The award was recorded at a price of $0.00 per share, indicating a non-cash share grant rather than a market purchase. Following this transaction, his directly held stake increased to 139,141 Ordinary Shares, reflecting a compensation-related equity award and not an open-market trade.
NATAN DAVID reported acquisition or exercise transactions in this Form 4 filing.
Quantum Cyber N.V. director Natan David received a grant of ordinary shares as compensation. On May 8, 2026, he was awarded 137,141 ordinary shares at a stated price of $0.00 per share, bringing his directly held stake to 137,141 shares after the transaction.
Quantum Cyber N.V. Chief Executive Officer David E. Lazar reported new preferred share holdings and no beneficial ownership of ordinary shares. As of April 22, 2026, he beneficially owns 0 ordinary shares.
On that date, he was granted 1,000,000 Series D Preferred Shares and 1,000,000 Series E Preferred Shares at $1.50 per share, for an additional purchase price of $3,000,000. These Second Closing Shares follow a prior purchase of 1,000,000 Series A, 1,000,000 Series B, and 1,000,000 Series C Preferred Shares at $1.00 per share, totaling $3,000,000.
After stockholder approval on April 22, 2026, each First Closing Share is convertible into 9 ordinary shares and each Second Closing Share is convertible into 225 ordinary shares at the reporting person’s option for no additional consideration. Stockholders also approved increasing authorized ordinary shares to at least 900,000,000, a reverse stock split, conversion of all Preferred Shares into ordinary shares in compliance with Nasdaq rules, and election of Lazar and his designees to the board. Each class of Preferred Stock is perpetual with no expiration date.